Efecto de los probióticos como tratamiento alternativo para la mastitis humana

  1. Aguilar-Cordero, María José 1
  2. Leon-Rios, Ximena Alejandra 1
  3. Luque- Ortega, Alvaro 2
  4. Perez-Castillo, Iñigo 1
  5. Rivero-Blanco, Tania 1
  6. Mur-Villar, Norma 3
  1. 1 Facultad de Ciencias de la Salud, Universidad de Granada, España. Grupo de Investigación CTS 367. Plan Andaluz de Investigación. Junta de Andalucía. España
  2. 2 Facultad de Ciencias de la Salud, Universidad de Granada, España
  3. 3 Facultad de Ciencias Médicas de Cienfuegos. Cuba. Grupo de Investigación CTS 367. Plan Andaluz de Investigación. Junta de Andalucía. España
Show affiliations +
Journal:
Journal of Negative and No Positive Results: JONNPR

ISSN: 2529-850X

Year of publication: 2020

Volume: 5

Issue: 10

Pages: 1179-1194

Type: Article

DOI: 10.19230/JONNPR.3801 DIALNET GOOGLE SCHOLAR lock_openDialnet editor

More publications in: Journal of Negative and No Positive Results: JONNPR

Sustainable development goals

Abstract

The aim of this study is to determine the effect of the use of probiotics in relation to mastitis, as well as to  know the adequate dose of probiotic and the ideal week of gestation so that the desired effect appears. For  this, a systematic review has been carried out, with a search string and filters according to each of the  different bases. Also, an inverse search was performed to the root of the results obtained. Inclusion and  exclusion criteria have been applied in the selection of articles. Regarding the results and according to  current evidence, it can be said that the use of probiotics as an alternative treatment to human mastitis could be effective since there is a statistically significant difference in the reduction of bacterial load. Regarding the  dose and the ideal week of gestation for the administration of probiotics, different doses and weeks havebeen determined that have taken effect; but without being able to specify problems they are the most  effective and ideal.  

Bibliographic References

  • World Health Organization. Mastitis: causes and management. Geneva: World Health Organization. 2000. Disponible en: https://www.who.int/maternal_child_adolescent/documents/fch_cah_00_13/es/
  • Turck D, Bresson J, Burlingame B, Dean T, Fairweather-tait S, Heinonen M, et al. Lactobacillus fermentum CECT 5716 and a reduction of the Staphylococcus load in breast milk which reduces the risk of infectious mastitis : evaluation of a health claim pursuant to Article 14 of Regulation ( EC ) No 1924 / 2006. EFSA J. 2017;15(7):4917.
  • Bond DM, Morris JM, Nassar N. Study protocol: Evaluation of the probiotic Lactobacillus Fermentum CECT5716 for the prevention of mastitis in breastfeeding women: A randomised controlled trial. BMC Pregnancy Childbirth [Internet]. 2017;17:148. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019364086&doi=10.1186%2Fs12884-017-1330-8&partnerID=40&md5=cc73c81a035c9cbcf210784dbd3c61df
  • Hurtado JA, Maldonado-Lobón JA, Díaz-Ropero MP, Flores-Rojas K, Uberos J, Leante JL, et al. Oral Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomized Controlled Trial. Breastfeed Med [Internet]. 2017;12(4):202–9. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019403288&doi=10.1089%2Fbfm.2016.0173&partnerID=40&md5=2c17e39e4b5eb21dabfe2410fb3969d4
  • de Andrés J, Jiménez E, Espinosa-Martos I, Rodríguez JM, Garcia-Conesa MT. An Exploratory Search for Potential Molecular Targets Responsive to the Probiotic Lactobacillus salivarius PS2 in Women With Mastitis: Gene Expression Profiling vs. Interindividual Variability. Front Microbiol. 2018;9.
  • Vázquez-Fresno R, Llorach R, Marinic J, Tulipani S, Garcia-Aloy M, Espinosa-Martos I, et al. Urinary metabolomic fingerprinting after consumption of a probiotic strain in women with mastitis. Pharmacol Res [Internet]. 2014;87:1605. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84907597628&doi=10.1016%2Fj.phrs.2014.05.010&partnerID=40&md5=6c953640e7203cc9a5b9728f9077312d
  • Arroyo R, Martín V, Maldonado A, Jiménez E, Rodríguez JM. Treatment of Infectious Mastitis during Lactation : Antibiotics versus Oral Administration of Lactobacilli Isolated from Breast Milk. Clin Infect Dis. 2010;50(12):1551– 8.
  • Fernández L, Langa S, Martín V, Maldonado A, Jiménez E, Martín R, et al. The human milk microbiota : Origin and potential roles in health and disease. Pharmacol Res [Internet]. 2013;69(1):1–10. Disponible en: http://dx.doi.org/10.1016/j.phrs.2012.09.001
  • Jiménez E, Fernández L, Maldonado A, Martín R, Olivares M, Xaus J, et al. Oral Administration of Lactobacillus Strains Isolated from Breast Milk as an Alternative for the Treatment of Infectious Mastitis during Lactation. 2008;74(15):4650–5.
  • Espinosa-Martos I, Jiménez E, de Andrés J, Rodríguez-Alcala LM, Tavárez S, Manzano S, et al. Milk and blood biomarkers associated to the clinical efficacy of a probiotic for the treatment of infectious mastitis. Benef Microbes. 2016;7(3):305–18.
  • Marín M, Arroyo R, Espinosa-Martos I, Fernández L, Rodríguez JM. Identification of Emerging Human Mastitis Pathogens by MALDI-TOF and Assessment of Their Antibiotic Resistance Patterns. 2017;8:1258.
  • Angelopoulou A, Field D, Ryan CA, Stanton C, Hill C, Ross RP. The microbiology and treatment of human mastitis. Med Microbiol Immunol [Internet]. 2018;207(2):83–94. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85040689037&doi=10.1007%2Fs00430-017-0532-z&partnerID=40&md5=16d715c2ec35b4c5e20fd157aedec269
  • Castro A, González M, Tarín JJ, Cano A. Role of probiotics in obstetrics and gynecology [Papel de los probióticos en Obstetricia y Ginecología]. Nutr Hosp [Internet]. 2015;31:26–9. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923847889%7B&%7Ddoi=10.3305%7B%25%7D2Fnh.2015.31.sup1.8704%7B&%7DpartnerID=40%7B&%7Dmd5=f 1462fae4b763b756a125f6ada50e87f
  • Beltrán DA, Crespo AE, Rodriguez TC, Garcia Á. Infectious mastitis: A new solution for an old problem [Mastitis infecciosa: Nueva solución para un viejo problema]. Nutr Hosp [Internet]. 2015;31:89–95. Disponible en:
  • https://www.scopus.com/inward/record.uri?eid=2-s2.0-84923852152%7B&%7Ddoi=10.3305%7B%25%7D2Fnh.2015.31.sup1.8714%7B&%7DpartnerID=40%7B&%7Dmd5=6 5b9de872dabaa6a56e84717369749cc
  • Vayas R, Carrera L. Actualización en el manejo de las mastitis infecciosas durante la lactancia. 2012;5(1):25–9.
  • Fernández L, Cárdenas N, Arroyo R, Manzano S, Jiménez E, Martín V, et al. Prevention of Infectious Mastitis by Oral Administration of Lactobacillus salivarius PS2 during Late Pregnancy. Clin Infect Dis [Internet]. 2016;62(5):568–73. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960121427&doi=10.1093%2Fcid%2Fciv974&partnerID=40&md5=042286a05823e99eecac7c4d16bd8a34
  • Carrera M, Arroyo R, Mediano P, Fernández L, Marín M, Rodríguez J. Lactancia materna y mastitis. Tratamiento empírico basado en la sintomatología y los agentes etiológicos. Acta Pediatr Esp. 2012;70(6):255–61.
  • Fernández L, García C, Carrera M, Mediano P, Rodríguez J, Marín M. Factores de riesgo de la mastitis infecciosa durante la lactancia. 2016;74(11):243–50.
  • Mediano P, Fernández L, Rodríguez JM, Marín M. Case – control study of risk factors for infectious mastitis in Spanish breastfeeding women. 2014;14:195.
  • Urrútia G, Bonfill X. Declaración PRISMA: una propuesta para mejorar la publicación de revisiones sistemáticas y metaanálisis. Med Clin. 2010;135(11):507–11.
  • Cabello JB por CASPe. Plantilla para ayudarte a entender un Ensayo Clínico. En: CASPe. Guías CASPe Lectura Crítica de la Literatura Médica. Alicante: CASPe; 2005.
  • Jcr.clarivate.com [Internet]. United Kingdom: Clarivate analytics; 2018 [actualizado 20 Sep 2018; consultado 7 mar 2019]. Disponible en: https://jcr.clarivate.com/JCRJournalHomeAction.action
  • Maldonado-Lobón JA, Díaz-López MA, Carputo R, Duarte P, Díaz-Ropero MP, Valero AD, et al. Lactobacillus fermentum CECT 5716 Reduces Staphylococcus Load in the Breastmilk of Lactating Mothers Suffering Breast Pain: A Randomized Controlled Trial. Breastfeed Med [Internet]. 2015;10(9):425–32. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84946080205&doi=10.1089%2Fbfm.2015.0070&partnerID=40&md5=9f4699aee7dc64d1dad589315e208211
  • Mastromarino P, Capobianco D, Miccheli A, Praticò G, Campagna G, Laforgia N, Capursi T, Baldassarre ME. Administration of a multistrain probiotic product (VSL#3) to women in the perinatal period differentially affects breast milk beneficial microbiota in relation to mode of delivery. Pharmacol Res. 2015 May-Jun;95-96:63-70. doi:
  • j.phrs.2015.03.013. Epub 2015 Mar 31.
  • Fernández L, Cárdenas N, Arroyo R, Manzano S, Jiménez E, Martín V, et al. Prevention of Infectious Mastitis by Oral Administration of Lactobacillus salivarius PS2 during Late Pregnancy. Clin Infect Dis [Internet]. 2016;62(5):568–73. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-84960121427&doi=10.1093%2Fcid%2Fciv974&partnerID=40&md5=042286a05823e99eecac7c4d16bd8a34
  • Jamilian M, Bahmani F, Vahedpoor Z, Salmani A, Tajabadi M, Jafari P, et al. Effects of Probiotic Supplementation on Metabolic Status in Pregnant Women: a Randomized, Double-blind, Placebo-Controlled Trial. Arch Iran Med. 2016;19(10):687–92.
  • Bond DM, Morris JM, Nassar N. Study protocol: Evaluation of the probiotic Lactobacillus Fermentum CECT5716 for the prevention of mastitis in breastfeeding women: A randomised controlled trial. BMC Pregnancy Childbirth [Internet]. 2017;17:148. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019364086&doi=10.1186%2Fs12884-017-1330-8&partnerID=40&md5=cc73c81a035c9cbcf210784dbd3c61df
  • Hurtado JA, Maldonado-Lobón JA, Díaz-Ropero MP, Flores-Rojas K, Uberos J, Leante JL, et al. Oral Administration to Nursing Women of Lactobacillus fermentum CECT5716 Prevents Lactational Mastitis Development: A Randomized Controlled Trial. Breastfeed Med [Internet]. 2017;12(4):202–9. Disponible en: https://www.scopus.com/inward/record.uri?eid=2-s2.0-85019403288&doi=10.1089%2Fbfm.2016.0173&partnerID=40&md5=2c17e39e4b5eb21dabfe2410fb3969d4
  • De Andrés J, Jiménez E, Espinosa-Martos I, Rodríguez JM, Garcia-Conesa MT. An Exploratory Search for Potential Molecular Targets Responsive to the Probiotic Lactobacillus salivarius PS2 in Women With Mastitis: Gene Expression Profiling vs. Interindividual Variability. Front Microbiol. 2018;9.
  • Karlsson S, Brantsæter AL, Meltzer HM, Jacobsson B, Barman M, Sengpiel V.Maternal probiotic milk intake during pregnancy and breastfeeding complications in the Norwegian Mother and Child Cohort Study. Eur J Nutr. 2019 Sep 10. doi: 10.1007/s00394-019-02072-8. [Epub ahead of print]
Data source: Dialnet